Lam S C, Plow E F, D'Souza S E, Cheresh D A, Frelinger A L, Ginsberg M H
Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.
J Biol Chem. 1989 Mar 5;264(7):3742-9.
Glycoprotein IIb-IIIa is the most prominent Arg-Gly-Asp (RGD)-binding adhesion receptor on platelets. By affinity chromatography on an immobilized RGD peptide, we have investigated the possible existence of other platelet-associated adhesion receptors that bind RGD peptides. When an octyl glucoside extract of surface-radioiodinated platelets was applied to an affinity matrix of KYGRGDS-coupled Sepharose 4B, a 160-kDa-labeled protein (P160) and GPIIb-IIIa bound and were specifically eluted by soluble GRGDSP peptide, but not by the variant GRGESP peptide. Furthermore, a dodecapeptide corresponding to fibrinogen gamma 400-411 eluted only GPIIb-IIIa but not P160 from the RGD affinity matrix. Characterization of P160 by two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and by the O'Farrell gel electrophoresis system indicated that P160 is a component of platelet GPIc. GoH3, a monoclonal antibody recognizing the alpha subunit of the very late antigen-6, failed to immunoprecipitate P160 from the RGD eluate, indicating that it did not contain the very late antigen-6 alpha subunit. In immunoblots, P160 reacted specifically with a polyclonal anti-peptide antibody recognizing the alpha subunit of the vitronectin receptor (VnR), but not with the monoclonal anti-GPIIb antibody PMI-1, suggesting that P160 is the alpha subunit of platelet VnR. This possibility was further substantiated by the complete identity between the determined amino-terminal sequence of P160 and the known sequence of the VnR alpha subunit. Moreover, direct association of P160 with a beta subunit having an apparent molecular weight similar to that of GPIIIa was demonstrated by immunoprecipitation with LM609, an anti-VnR complex monoclonal antibody. These results indicate that the VnR complex is present on platelets and may play a functional role in platelet adhesive reactions.
糖蛋白IIb-IIIa是血小板上最突出的能结合精氨酸-甘氨酸-天冬氨酸(RGD)的黏附受体。通过在固定化RGD肽上进行亲和层析,我们研究了血小板中其他可能结合RGD肽的相关黏附受体的存在情况。当将表面放射性碘化血小板的辛基葡糖苷提取物应用于偶联了KYGRGDS的琼脂糖4B亲和基质时,一种160 kDa的标记蛋白(P160)和糖蛋白IIb-IIIa与之结合,并被可溶性GRGDSP肽特异性洗脱,但不能被变体GRGESP肽洗脱。此外,对应于纤维蛋白原γ400 - 411的十二肽只能从RGD亲和基质上洗脱糖蛋白IIb-IIIa,而不能洗脱P160。通过二维十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和奥法雷尔凝胶电泳系统对P160进行表征,结果表明P160是血小板糖蛋白Ic的一个组分。GoH3是一种识别极晚期抗原-6α亚基的单克隆抗体,它不能从RGD洗脱物中免疫沉淀P160,这表明P160不包含极晚期抗原-6α亚基。在免疫印迹中,P160与识别玻连蛋白受体(VnR)α亚基的多克隆抗肽抗体发生特异性反应,但不与单克隆抗糖蛋白IIb抗体PMI-1反应,这表明P1,60是血小板VnR的α亚基。P160的测定氨基末端序列与已知的VnRα亚基序列完全相同,进一步证实了这种可能性。此外,用抗VnR复合物单克隆抗体LM609进行免疫沉淀,证明P160与一种表观分子量与糖蛋白IIIa相似的β亚基直接相关。这些结果表明VnR复合物存在于血小板上,并且可能在血小板黏附反应中发挥功能作用。